Global Non-Invasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Non-Invasive Cancer Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 CTCs
  • 1.4.3 CTNAS
  • 1.4.4 Exosomes
• 1.5 Market by Application
  • 1.5.1 Global Non-Invasive Cancer Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Blood
  • 1.5.3 Urine
  • 1.5.4 Saliva
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Non-Invasive Cancer Diagnostics Market Perspective (2015-2026)
• 2.2 Global Non-Invasive Cancer Diagnostics Growth Trends by Regions
  • 2.2.1 Non-Invasive Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Non-Invasive Cancer Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Non-Invasive Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Non-Invasive Cancer Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Non-Invasive Cancer Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Non-Invasive Cancer Diagnostics Players by Market Size
  • 3.1.1 Global Top Non-Invasive Cancer Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio
  • 3.2.1 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Diagnostics Revenue in 2019
• 3.3 Non-Invasive Cancer Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
• 3.5 Date of Enter into Non-Invasive Cancer Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Non-Invasive Cancer Diagnostics Market Size (2015-2020)
• 6.2 Non-Invasive Cancer Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Non-Invasive Cancer Diagnostics Market Size (2015-2020)
• 7.2 Non-Invasive Cancer Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Non-Invasive Cancer Diagnostics Market Size (2015-2020)
• 8.2 Non-Invasive Cancer Diagnostics Key Players in China (2019-2020)
• 8.3 China Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
• 8.4 China Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Non-Invasive Cancer Diagnostics Market Size (2015-2020)
• 9.2 Non-Invasive Cancer Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Non-Invasive Cancer Diagnostics Market Size (2015-2020)
• 10.2 Non-Invasive Cancer Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Non-Invasive Cancer Diagnostics Market Size (2015-2020)
• 11.2 Non-Invasive Cancer Diagnostics Key Players in India (2019-2020)
• 11.3 India Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
• 11.4 India Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Non-Invasive Cancer Diagnostics Market Size (2015-2020)
• 12.2 Non-Invasive Cancer Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Gen-Probe Inc
  • 13.1.1 Gen-Probe Inc Company Details
  • 13.1.2 Gen-Probe Inc Business Overview
  • 13.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction
  • 13.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020))
  • 13.1.5 Gen-Probe Inc Recent Development
• 13.2 Digene Corporation
  • 13.2.1 Digene Corporation Company Details
  • 13.2.2 Digene Corporation Business Overview
  • 13.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction
  • 13.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.2.5 Digene Corporation Recent Development
• 13.3 Quest Diagnostics Inc
  • 13.3.1 Quest Diagnostics Inc Company Details
  • 13.3.2 Quest Diagnostics Inc Business Overview
  • 13.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction
  • 13.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.3.5 Quest Diagnostics Inc Recent Development
• 13.4 Cancer, Genetics Inc
  • 13.4.1 Cancer, Genetics Inc Company Details
  • 13.4.2 Cancer, Genetics Inc Business Overview
  • 13.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction
  • 13.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.4.5 Cancer, Genetics Inc Recent Development
• 13.5 BIOVIEW Inc
  • 13.5.1 BIOVIEW Inc Company Details
  • 13.5.2 BIOVIEW Inc Business Overview
  • 13.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction
  • 13.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.5.5 BIOVIEW Inc Recent Development
• 13.6 AVIVA Biosciences Corporation
  • 13.6.1 AVIVA Biosciences Corporation Company Details
  • 13.6.2 AVIVA Biosciences Corporation Business Overview
  • 13.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction
  • 13.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.6.5 AVIVA Biosciences Corporation Recent Development
• 13.7 Laboratory Corporation of America Holdings (LabCorp)
  • 13.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
  • 13.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
  • 13.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction
  • 13.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
• 13.8 A&G Pharmaceutical
  • 13.8.1 A&G Pharmaceutical Company Details
  • 13.8.2 A&G Pharmaceutical Business Overview
  • 13.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction
  • 13.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.8.5 A&G Pharmaceutical Recent Development
• 13.9 Affymetrix Inc
  • 13.9.1 Affymetrix Inc Company Details
  • 13.9.2 Affymetrix Inc Business Overview
  • 13.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction
  • 13.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.9.5 Affymetrix Inc Recent Development
• 13.10 Precision Therapeutics
  • 13.10.1 Precision Therapeutics Company Details
  • 13.10.2 Precision Therapeutics Business Overview
  • 13.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction
  • 13.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  • 13.10.5 Precision Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer